End-of-life targeted degradation of DAF-2 insulin/IGF-1 receptor promotes longevity free from growth-related pathologies is a research paper published in eLife (2021). On theSindex it has a DataRank of 0. It has been cited 66 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Grant: PP00P3_163898
Research Council of Norway
Grant: FRIMEDBIO-286499
Swiss National Science Foundation
Grant: 163898
The role of extracellular matrix enhancement in promoting healthy aging
NIH HHS
Grant: P40 OD010440
The Research Council of Norway
Grant: 286499
FROM RNA REGULATION TO FAT LOSS
National Institutes of Health
Grant: 1P40OD010440-01
Caenorhabditis Genetics Center
FWCI
3.45
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals